Global Biopharmaceuticals Market is Estimated to Reach $405 Billion by 2024

1. VARIANT MARKET RESEARCH 1

2. VARIANT MARKET RESEARCH Global Biopharmaceuticals Market is estimated to reach $405 billion by 2024; growing at a CAGR of 9.3% from 2016 to 2024. Biopharmaceuticals are medical drugs produced by the means of biotechnology methods comprising recombinant DNA techniques, purification processes, and hybridoma techniques. A potentially provocative technique of producing biopharmaceuticals involves transgenic organisms, mainly plants and animals, that have been genetically improved to produce drugs. They are proteins in nature including antibodies and nucleic acids (DNA, RNA or antisense oligonucleotides) used for vivo diagnostic purpose and therapeutic. Biopharmaceuticals are used in the treatment of several chronic diseases such as metabolic, neurological, cardiovascular, cancer, and other intermittent diseases for which there remain no available treatments. Browse categories/pharmaceuticals/biopharmaceuticals-market Complete Report @ https://www.variantmarketresearch.com/report- Global Biopharmaceuticals Market Size and Forecast, 2015 - 2024 (US$ Billion) Major factors driving the growth of global biopharmaceuticals market include enhanced efficiency over conventional drug, higher prevalence of diseases such as autoimmune diseases and cancer, and technological advancements. However, factors such as, entry of low-cost biosimilars, high costs of biopharmaceuticals, and risk of adverse effect posed by biopharmaceuticals may hinder the growth of the market. Furthermore, increasing research & development effort for product innovation, increasing government spending on pharmaceutical companies for the development of more effective products to treat life-threating diseases, and rising perveance of herbal medicine would provide the new business opportunities for the market in the coming years. 2

3. VARIANT MARKET RESEARCH The global biopharmaceuticals market has been segmented into type, therapeutic application, and geography. By type, it is segmented into monoclonal antibodies, recombinant proteins, granulocyte colony-stimulating factor (G-CSF), interferon, recombinant human insulin, erythropoietin, vaccines, growth hormones, purified proteins, and others. Therapeutic application is further bifurcated into oncology, inflammatory infectious diseases, metabolic disorders, cardiovascular diseases, and others. Global Biopharmaceuticals market share by region, 2024 (value%) By geography, the biopharmaceuticals market has been categorized into North America, Europe, Asia-Pacific, and Rest of the World (Row). The U.S., Canada, and Mexico are covered under North America wherein Europe covers Germany, UK, France, Italy, and others. Asia-Pacific covers India, Japan, China, and others. Rest of the World (Row) covers South America, Middle East, and Africa. Major companies operating in the global biopharmaceuticals market include Roche Holding AG, Bayer AG, Abbott Laboratories, Biocon Ltd, Eli Lilly and Company, Ranbaxy Laboratories Ltd., Pfizer Inc., Novartis AG, Genentech, Inc., and Johnson & Johnson, Inc, among others. Get categories/pharmaceuticals/biopharmaceuticals-market/sample-request Sample Report @ https://www.variantmarketresearch.com/report- The key takeaways from the report •The report will provide detailed analysis of Biopharmaceuticals Market with respect to major segments such as type, therapeutic application, and geography •The report will include the qualitative and quantitative analysis with market estimation over 2015-2024 and compound annual growth rate (CAGR) between 2016 and 2024 3

4. VARIANT MARKET RESEARCH •Comprehensive analysis of market dynamics including factors and opportunities will be provided in the report •An exhaustive regional analysis of Biopharmaceuticals Market has been included in the report •Profile of the key players of the Biopharmaceuticals Market will be provided, which include key financials, product & services, new developments and business strategies Scope of Biopharmaceuticals Market Type Segments •Monoclonal Antibodies •Recombinant Proteins •Granulocyte Colony-Stimulating Factor (G-CSF) •Interferon •Recombinant Human Insulin •Erythropoietin •Vaccines •Growth Hormones •Purified Proteins •Other Types Therapeutic Application segments •Oncology •Inflammatory Infectious Diseases •Metabolic Disorders •Cardiovascular Diseases •Other Therapeutic Applications Geography Segments •North America oU.S. oCanada oMexico •Europe oGermany oUK oFrance oItaly oOthers •Asia-Pacific oIndia 4

5. VARIANT MARKET RESEARCH oJapan oChina oOthers •RoW oSouth America oMiddle East oAfrica Table of Content Chapter 1 Prefix 1.1 Market Scope 1.2 Report Description 1.3 Research Methodology 1.3.1 Primary Research 1.3.2 Secondary Research 1.3.3 In-house Data Modeling Chapter 2 Executive Summary Chapter 3 Market Outline 3.1 Market Inclination, Trend, Outlook and Viewpoint 3.2 Market Share Analysis: Company’s Competitive Scenario 3.3 Value Chain Analysis 3.4 Market Dynamics 3.4.1 Drivers 3.4.1.1 Impact Analysis 3.4.2 Restraints 3.4.2.1 Impact Analysis 3.4.3 Opportunities 3.5 Porter’s five forces analysis 3.5.1 Factors Impact Analysis ………………………………… 5

6. VARIANT MARKET RESEARCH Chapter 7 Company Profiles 7.1 Roche Holding AG 7.2 Bayer AG 7.3 Abbott Laboratories 7.4 Biocon Ltd 7.5 Eli Lilly and Company 7.6 Ranbaxy Laboratories Ltd. 7.7 Pfizer Inc. 7.8 Novartis AG 7.9 Genentech, Inc. 7.10 Johnson & Johnson, Inc Contact Us: VARIANT MARKET RESEARCH LLP Web: https://www.variantmarketresearch.com/ Address: 649 Mission St., 5th Floor, San Francisco, CA 94105, United States. Tel: +1-415-680-2785 Fax: +1-415-680-2786 Email: help@variantmarketresearch.com 6